

Name | Size/Type | Description | Date |
---|---|---|---|
T-Carbo-F consent | 117KB PDF | T-Carbo-F consent | 13 Apr 2021 |
Talazoparib consent | 107KB PDF | Talazoparib consent | 04 Apr 2024 |
Temozolomide consent | 111KB PDF | Temozolomide consent | 05 Jun 2020 |
Tepotinib consent | 112KB PDF | Tepotinib consent | 05 Oct 2021 |
Tepotinib consent | 112KB PDF | Tepotinib consent | 08 Oct 2021 |
Tivozanib consent | 111KB PDF | Tivozanib consent | 21 Apr 2020 |
Topotecan & Cisplatin consent | 112KB PDF | Topotecan & Cisplatin consent | 21 Apr 2020 |
Topotecan consent | 111KB PDF | Topotecan consent | 21 Apr 2020 |
TPF consent | 116KB PDF | TPF consent | 13 Apr 2021 |
Trametinib consent | 111KB PDF | Trametinib consent | 07 Sep 2020 |
Trastuzumab (Herceptin or Ontruzant) consent | 133KB PDF | Trastuzumab (Herceptin or Ontruzant) consent | 21 Apr 2020 |
Trifluridine & Tipiracil (Lonsurf) consent | 112KB PDF | Trifluridine & Tipiracil (Lonsurf) consent | 21 Apr 2020 |
Tucatinib + Capecitabine + trastuzumab consent | 117KB PDF | Tucatinib + Capecitabine + trastuzumab consent | 08 Apr 2022 |
All consent forms on this website are for the use of St Luke’s Cancer Alliance staff in respect of St Luke’s Cancer Alliance patients only.
For those who do not work within St Luke’s Cancer Alliance:
Use of this site and any information on it is at your own risk. We do not accept responsibility for the use of any information that may be set out on the website. You assume full responsibility for the use of the information. You may wish to take your own legal advice before using any of the consent forms.
Please note that the consent forms below are not tumour-specific; one consent form may be used to consent patients for more than one St Luke’s Alliance chemotherapy protocol which uses the same combination of chemotherapy.
These consent forms should act as an aide-memoire to health professionals and patients, by providing a check-list of the kind of information which patients should be offered, and by enabling the patient to have a written record of the main points discussed.
The relevant Macmillan leaflet(s) should also be provided to each patient before consent. In no way should written information given to the patient be regarded as a substitute for face-to-face discussions with the patient.
These consent forms are for solid tumour chemotherapy only, and are NOT to be used for chemo-radiotherapy regimens.